Affinity Asset Advisors, LLC

Holdings History for ALNYLAM PHARMACEUTICALS INC - NOTE 1.000% 9/1

Investment type: Debt / NOTE 1.000% 9/1

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Principal	Change	Activity %	Price	All Holders
30 Sep 2024		-2.6%	$0	0	-15,000,000	-100%	147.05%	Q3 2024
30 Jun 2024	2.6%	+0.88%	$16,200,000	15,000,000	+5,000,000	+50%	108.0%	Q2 2024
31 Mar 2024	1.5%	+1.5%	$9,448,755	10,000,000	+10,000,000	NEW	94.49%	Q1 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.